Xiaobo Yang1,2, You Shang1,2. 1. Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2. Research Center for Translational Medicine, Jinyintan Hospital, Wuhan, China.
Dr Jecko Trachil stressed the possibility of platelet consumption forming pulmonary thrombi in patients with COVID‐19,
which coincides with the theory we are working on right now that pulmonary thrombi may be responsible for hypoxemia before typical acute respiratory distress syndrome develops,
called silent hypoxemia by some experts.
As for anti‐platelet drugs attenuating thrombi formation, the balance would be too delicate to maintain, because they may interfere with the platelet blocking viral invasion.
CONFLICTS OF INTEREST
The authors declare that they have no conflicts of interest.